Indication
Cystic Fibrosis Lung
2 clinical trials
3 products
Clinical trial
An Open-label, Phase 1/2 Trial of Gene Therapy 4D-710 in Adults With Cystic FibrosisStatus: Recruiting, Estimated PCD: 2026-12-01
Product
4D-710Product
RSP-1502Clinical trial
A Double-Blind, Active-Controlled, Multiple-Ascending Dose, Phase 1b Study of Aerosolized RSP-1502 Delivered Via the PARI LC Plus® Nebulizer in Subjects With Cystic Fibrosis and Chronic Pseudomonas Aeruginosa Lung InfectionStatus: Recruiting, Estimated PCD: 2025-04-01